175 related articles for article (PubMed ID: 36185590)
21. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
[TBL] [Abstract][Full Text] [Related]
22. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
[TBL] [Abstract][Full Text] [Related]
23. Acute versus chronic myocardial injury and long-term outcomes.
Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
[TBL] [Abstract][Full Text] [Related]
24. External Validation and Extension of a Clinical Score for the Discrimination of Type 2 Myocardial Infarction.
Nestelberger T; Lopez-Ayala P; Boeddinghaus J; Strebel I; Rubini Gimenez M; Huber I; Wildi K; Wussler D; Koechlin L; Prepoudis A; Gualandro DM; Puelacher C; Glarner N; Haaf P; Frey S; Bakula A; Wick R; Miró Ò; Martin-Sanchez FJ; Kawecki D; Keller D; Twerenbold R; Mueller C
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33803801
[TBL] [Abstract][Full Text] [Related]
25. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
[TBL] [Abstract][Full Text] [Related]
26. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
[TBL] [Abstract][Full Text] [Related]
27. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
[TBL] [Abstract][Full Text] [Related]
28. Type 2 Myocardial Infarction: A Geriatric Population-based Model of Pathogenesis.
Putot A; Jeanmichel M; Chague F; Manckoundia P; Cottin Y; Zeller M
Aging Dis; 2020 Feb; 11(1):108-117. PubMed ID: 32010485
[TBL] [Abstract][Full Text] [Related]
29. Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
Schulte C; Barwari T; Joshi A; Theofilatos K; Zampetaki A; Barallobre-Barreiro J; Singh B; Sörensen NA; Neumann JT; Zeller T; Westermann D; Blankenberg S; Marber M; Liebetrau C; Mayr M
Circ Res; 2019 Jul; 125(3):328-340. PubMed ID: 31159652
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction.
Biener M; Giannitsis E; Thum T; Bär C; Costa A; Andrzejewski T; Stoyanov KM; Vafaie M; Meder B; Katus HA; de Gonzalo-Calvo D; Mueller-Hennessen M
Eur Heart J Acute Cardiovasc Care; 2021 Aug; 10(6):653-660. PubMed ID: 33580779
[TBL] [Abstract][Full Text] [Related]
31. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
[TBL] [Abstract][Full Text] [Related]
32. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
33. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
[TBL] [Abstract][Full Text] [Related]
34. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury].
Li Z; Cui S; Geng L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):443-448. PubMed ID: 34053488
[TBL] [Abstract][Full Text] [Related]
35. Differences between cardiac troponin I vs. T according to the duration of myocardial ischaemia.
Espinosa AS; Hussain S; Al-Awar A; Jha S; Elmahdy A; Kalani M; Kakei Y; Zulfaj E; Aune E; Poller A; Bobbio E; Thoirleifsson S; Zeijlon R; Gudmundursson T; Wernbom M; Lindahl B; Polte CL; Omerovic E; Hammarsten O; Redfors B
Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):355-363. PubMed ID: 36848390
[TBL] [Abstract][Full Text] [Related]
36. Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification.
Chapman AR; Sandoval Y
Clin Chem; 2021 Jan; 67(1):61-69. PubMed ID: 33418588
[TBL] [Abstract][Full Text] [Related]
37. Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).
Collinson PO; Gaze DC; Thokala P; Goodacre S
Health Technol Assess; 2013; 17(15):v-vi, 1-122. PubMed ID: 23597479
[TBL] [Abstract][Full Text] [Related]
38. Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
Lee WJ; Cheng H; Whitney BM; Nance RM; Britton SR; Jordahl K; Lindstrom S; Ruderman SA; Kitahata MM; Saag MS; Willig AL; Burkholder G; Eron JJ; Kovacic JC; Björkegren JLM; Mathews WC; Cachay E; Feinstein MJ; Budoff M; Hunt PW; Moore RD; Keruly J; McCaul ME; Chander G; Webel A; Mayer KH; Delaney JA; Crane PK; Martinez C; Crane HM; Hao K; Peter I
Int J Cardiol; 2023 Jul; 383():15-23. PubMed ID: 37149004
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
Jernberg T; Lindahl B; Siegbahn A; Andren B; Frostfeldt G; Lagerqvist B; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2003 Dec; 42(11):1909-16. PubMed ID: 14662251
[TBL] [Abstract][Full Text] [Related]
40. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.
Rittoo D; Jones A; Lecky B; Neithercut D
J Am Coll Cardiol; 2014 Jun; 63(22):2411-20. PubMed ID: 24747102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
